TumCMig Cancer Research Results

TumCMig, Tumor cell migration: Click to Expand ⟱
Source:
Type:
Tumor cell migration is a critical process in cancer progression and metastasis, which is the spread of cancer cells from the primary tumor to distant sites in the body.


Ovarian, Ovarian Cancer: Click to Expand ⟱
Ovarian Cancer


Scientific Papers found: Click to Expand⟱
7394- Amla,    Emblica officinalis extract downregulates pro-angiogenic molecules via upregulation of cellular and exosomal miR-375 in human ovarian cancer cells
- vitro+vivo, Ovarian, NA
antiNeop↑, TumCP↓, TumCMig↓, TumCI↓, TumCG↓, miR-375↑, IGFR↓, Snail↓, E-cadherin↑,
722- Bor,    Boric acid as a promising agent in the treatment of ovarian cancer: Molecular mechanisms
- in-vitro, Ovarian, MDAH-2774
TumCP↓, TumCI↓, TumCMig↓, Apoptosis↑, ROS↑, miR-21↓, miR-130a↓, Casp8∅, Casp10∅, cycD1/CCND1∅, CDK6∅, CDK4∅, FADD∅, DR4∅, DR5∅,
5941- Cela,    Celastrol inhibits migration and invasion through blocking the NF-κB pathway in ovarian cancer cells
- in-vitro, Ovarian, SKOV3 - in-vitro, Ovarian, OVCAR-3
TumCMig↓, TumCI↓, NF-kB↓, p65↓, MMP9↓, eff↑, AntiTum↑, Inflam↓, AntiDiabetic↑,
1247- EMD,    Emodin exerts antitumor effects in ovarian cancer cell lines by preventing the development of cancer stem cells via epithelial mesenchymal transition
- vitro+vivo, Ovarian, SKOV3 - in-vitro, Ovarian, A2780S
TumCP↓, TumCMig↓, TumCI↓, EMT↓, N-cadherin↓, Vim↓, E-cadherin↑, TumCG↓, CD133↓, OCT4↓, CSCs↓,
6970- Form,    Formononetin, an isoflavone from Astragalus membranaceus inhibits proliferation and metastasis of ovarian cancer cells
- in-vitro, Ovarian, NA
tumCV↓, Apoptosis↑, Casp3↑, Casp9↑, Bax:Bcl2↑, TumCMig↓, TumCI↓, MMP2↓, MMP9↓, p‑ERK↓,
7262- Gink,    Ginkgetin suppresses ovarian cancer growth through inhibition of JAK2/STAT3 and MAPKs signaling pathways
- in-vitro, Ovarian, A2780S - in-vitro, Ovarian, SKOV3
Dose↝, TumCP↓, Apoptosis↑, TumCMig↓, TumCI↓, TumVol↓, p‑STAT3↓, p‑ERK↓, IR↓,
7364- HibSad,    Hibiscus sabdariffa calyx extract induces anti-proliferative and anti-migratory effects in ovarian cancer
- in-vitro, Ovarian, OVCAR-3
*Inflam↓, *AntiBio↑, *antiOx↑, TumCMig↓, AKT1↓, cycD1/CCND1↓,
3500- MF,    Moderate Static Magnet Fields Suppress Ovarian Cancer Metastasis via ROS-Mediated Oxidative Stress
- in-vitro, Ovarian, SKOV3
ROS↑, CSCs↓, CD44↓, SOX2↓, cMyc↓, TumMeta↓, TumCI↓, TumCMig↓, CD133↓, Nanog↓,
1128- Myr,    Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancer
- vitro+vivo, Ovarian, NA
MAPK↓, ERK↓, PI3K↓, Akt↓, p‑PARP↑, cl‑Casp3↑, Bax:Bcl2↑, TumCMig↓, SMAD3↓,
1805- NarG,    Naringenin suppresses epithelial ovarian cancer by inhibiting proliferation and modulating gut microbiota
- in-vitro, Ovarian, A2780S - in-vivo, NA, NA
TumCP↓, TumCMig↓, PI3K↓, TumVol↓, TumW↓, BioAv↑, GutMicro↑, Dose∅, eff↑, EGFR↓, cycD1/CCND1↓, toxicity∅,
1237- PTS,    Pterostilbene induces cell apoptosis and inhibits lipogenesis in SKOV3 ovarian cancer cells by activation of AMPK-induced inhibition of Akt/mTOR signaling cascade
- in-vitro, Ovarian, SKOV3
TumCMig↓, TumCI↓, MDA↑, ROS↑, BAX↑, Casp3↑, Bcl-2↓, SREBP1↓, FASN↓, AMPK↓, p‑AMPK↑, p‑P53↑, p‑TSC2↑, p‑Akt↓, p‑mTOR↓, p‑S6K↓, p‑4E-BP1↓,
5127- Sal,    Salinomycin repressed the epithelial–mesenchymal transition of epithelial ovarian cancer cells via downregulating Wnt/β-catenin pathway
- in-vitro, Ovarian, NA
TumCI↓, E-cadherin↑, N-cadherin↓, Vim↓, Wnt↓, β-catenin/ZEB1↓, TumCP↓, TumCMig↓, EMT↓,

Showing Research Papers: 1 to 12 of 12

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 12

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0)

miR-375↑, 1,  

Redox & Oxidative Stress(tgid=1)

MDA↑, 1,   ROS↑, 3,  

Core Metabolism/Glycolysis(tgid=4)

AKT1↓, 1,   AMPK↓, 1,   p‑AMPK↑, 1,   cMyc↓, 1,   FASN↓, 1,   IR↓, 1,   p‑S6K↓, 1,   SREBP1↓, 1,  

Cell Death(tgid=5)

Akt↓, 1,   p‑Akt↓, 1,   Apoptosis↑, 3,   BAX↑, 1,   Bax:Bcl2↑, 2,   Bcl-2↓, 1,   Casp10∅, 1,   Casp3↑, 2,   cl‑Casp3↑, 1,   Casp8∅, 1,   Casp9↑, 1,   DR4∅, 1,   DR5∅, 1,   FADD∅, 1,   MAPK↓, 1,  

Kinase & Signal Transduction(tgid=6)

p‑TSC2↑, 1,  

Transcription & Epigenetics(tgid=7)

miR-21↓, 1,   tumCV↓, 1,  

DNA Damage & Repair(tgid=10)

p‑P53↑, 1,   p‑PARP↑, 1,  

Cell Cycle & Senescence(tgid=11)

CDK4∅, 1,   cycD1/CCND1↓, 2,   cycD1/CCND1∅, 1,  

Proliferation, Differentiation & Cell State(tgid=12)

p‑4E-BP1↓, 1,   CD133↓, 2,   CD44↓, 1,   CSCs↓, 2,   EMT↓, 2,   ERK↓, 1,   p‑ERK↓, 2,   IGFR↓, 1,   p‑mTOR↓, 1,   Nanog↓, 1,   OCT4↓, 1,   PI3K↓, 2,   SOX2↓, 1,   p‑STAT3↓, 1,   TumCG↓, 2,   Wnt↓, 1,  

Migration(tgid=13)

E-cadherin↑, 3,   miR-130a↓, 1,   MMP2↓, 1,   MMP9↓, 2,   N-cadherin↓, 2,   SMAD3↓, 1,   Snail↓, 1,   TumCI↓, 9,   TumCMig↓, 12,   TumCP↓, 6,   TumMeta↓, 1,   Vim↓, 2,   β-catenin/ZEB1↓, 1,  

Angiogenesis & Vasculature(tgid=14)

EGFR↓, 1,  

Immune & Inflammatory Signaling(tgid=16)

Inflam↓, 1,   NF-kB↓, 1,   p65↓, 1,  

Hormonal & Nuclear Receptors(tgid=20)

CDK6∅, 1,  

Drug Metabolism & Resistance(tgid=21)

BioAv↑, 1,   Dose↝, 1,   Dose∅, 1,   eff↑, 2,  

Clinical Biomarkers(tgid=22)

EGFR↓, 1,   GutMicro↑, 1,  

Functional Outcomes(tgid=23)

AntiDiabetic↑, 1,   antiNeop↑, 1,   AntiTum↑, 1,   toxicity∅, 1,   TumVol↓, 2,   TumW↓, 1,  
Total Targets: 80

Pathway results for Effect on Normal Cells:


NA, unassigned(tgid=0)

AntiBio↑, 1,  

Redox & Oxidative Stress(tgid=1)

antiOx↑, 1,  

Immune & Inflammatory Signaling(tgid=16)

Inflam↓, 1,  
Total Targets: 3

Scientific Paper Hit Count for: TumCMig, Tumor cell migration
1 Phyllanthus emblica/Emblica officinalis/Amla / Indian Gooseberry
1 Boron
1 Celastrol
1 Emodin
1 Formononetin
1 Ginkgetin
1 Hibiscus sabdariffa
1 Magnetic Fields
1 Myricetin
1 Naringin
1 Pterostilbene
1 salinomycin
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:20  Cells:%  prod#:%  Target#:326  State#:%  Dir#:1
wNotes=0 sortOrder:rid,rpid

 

Home Page